focus -WSS

focus

author：fashion 2025-09-07 11:16:35 - browse：73725

Medicare and money photo illustration. — Adobe

WASHINGTON — A week after the Food and Drug Administration granted full, traditional approval to a new Alzheimer’s treatment, insurers are finalizing their plans to cover it as well as associated scans and diagnostic tests.

Medicare will cover most patients eligible for Leqembi, a new treatment developed by Eisai and Biogen to help slow the progression of Alzheimer’s disease. The drug, which has modest benefits, has potentially serious side effects for some patients including brain swelling and bleeding.

Medicare told STAT that it would cover brain scans and genetic testing that will help screen for and monitor potential side effects. Medicare already covers one amyloid PET scan per lifetime, but the agency is reconsidering that policy and plans to release a new proposed policy “soon,” an agency spokesperson said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Pregnancy discrimination could be enabled by AI

explore

hotspot

WSS

AI models in health care face new federal disclosure requirements

The unintended consequences of overturning Roe v. Wade

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Senate bill would ban some hospital facility fees

The struggle to figure out which patients 'deserve' Wegovy

hotspot

focus

hotspot

New air purifier tech could be key to improving indoor air quality

Free Covid tests will again be offered to all U.S. households

United colonoscopy coverage change 'may cost lives,' doctors say

FDA approves world's first CRISPR

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA weighs limits of animal data in assessing artificial wombs

At least 13 dead in Texas as scorching temps continue

Pfizer plans to depart BIO

Medical records are filled with copy

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Wikipedia

STAT letters to the editor on burnt

After sickle

Chemotherapy shortages won’t get better under Biden’s latest plan

Pregnancy discrimination could be enabled by AI

House panel takes first step toward fixing drug shortages

What PEPFAR has meant on the ground in Ukraine

focus

explore

hotspot

knowledge